Matches in Wikidata for { <http://www.wikidata.org/entity/Q76980914> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q76980914 description "clinical trial" @default.
- Q76980914 description "ensayu clínicu" @default.
- Q76980914 description "klinisch onderzoek" @default.
- Q76980914 description "клінічне випробування" @default.
- Q76980914 name "AZD9291 (Osimertinib) With or Without Bevacizumab as First-Treatment for Patients With EGFR-Mutant Lung Cancer" @default.
- Q76980914 name "AZD9291" @default.
- Q76980914 type Item @default.
- Q76980914 label "AZD9291 (Osimertinib) With or Without Bevacizumab as First-Treatment for Patients With EGFR-Mutant Lung Cancer" @default.
- Q76980914 label "AZD9291" @default.
- Q76980914 prefLabel "AZD9291 (Osimertinib) With or Without Bevacizumab as First-Treatment for Patients With EGFR-Mutant Lung Cancer" @default.
- Q76980914 prefLabel "AZD9291" @default.
- Q76980914 P1050 Q76980914-AD40ED21-F29A-4CA2-BA91-BDF371B0922D @default.
- Q76980914 P1132 Q76980914-3C52A3D1-C6F2-4256-9CCA-2825B9114E94 @default.
- Q76980914 P1476 Q76980914-DDF835D1-60BC-42C8-8EE9-9F8D1B1C52EE @default.
- Q76980914 P2899 Q76980914-6634645A-4F0F-4A79-9818-5B57D30E1F4D @default.
- Q76980914 P3098 Q76980914-351193C3-2F59-4CBA-92C8-CBDFEA002311 @default.
- Q76980914 P31 Q76980914-717E4F1B-ABC1-402D-BB6F-29C0AA13CE16 @default.
- Q76980914 P4844 Q76980914-71B01F6D-8FD4-4707-B7FE-5821229D3568 @default.
- Q76980914 P4844 Q76980914-B3BD71AD-609B-4BB2-A34A-5A73015684B5 @default.
- Q76980914 P4844 Q76980914-D08E89FE-D00B-4F04-9E0D-EFB0AB8EF44A @default.
- Q76980914 P580 Q76980914-AD49A4FB-1286-4835-B291-6F0E58936384 @default.
- Q76980914 P582 Q76980914-A5374095-DA29-44BC-8F98-7C7A3BD628BF @default.
- Q76980914 P6099 Q76980914-DA452E5E-9BA8-4282-A5A5-3C4698959C17 @default.
- Q76980914 P8363 Q76980914-A2B12C90-E53B-4F86-AEDB-4F99C1FB36CE @default.
- Q76980914 P1050 Q33525 @default.
- Q76980914 P1132 "+300" @default.
- Q76980914 P1476 "Randomized Phase III Study of Combination AZD9291 (Osimertinib) and Bevacizumab Versus AZD9291 (Osimertinib) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q76980914 P2899 "+18" @default.
- Q76980914 P3098 "NCT04181060" @default.
- Q76980914 P31 Q30612 @default.
- Q76980914 P4844 Q21506464 @default.
- Q76980914 P4844 Q413299 @default.
- Q76980914 P4844 Q50429626 @default.
- Q76980914 P580 "2020-07-10T00:00:00Z" @default.
- Q76980914 P582 "2025-09-01T00:00:00Z" @default.
- Q76980914 P6099 Q42824827 @default.
- Q76980914 P8363 Q78089383 @default.